Supplement: Visions of a Continuous Bioprocess Future
Challenges Remain in the Switch from Fed-Batch Biomanufacturing Operations
The 100,000 Genomes Club
10 Countries Meet the Mark for National Genome Projects
Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
In the mAb Race, Don’t Stumble at Characterization
Researchers Adapt Existing Techniques to Deal with Challenging New Monoclonal Antibodies
Martin O'Rourke Ph.D.
Martin O'Rourke, Ph.D., is senior director, oncology in vitro biosciences, integrated drug discovery at Charles River Laboratories.